Hydrochlorothiazide- 15 N 2 , 13 C,d 2

Overview

Hydrochlorothiazide - 15 N 2 , 13 C,d 2 is 15 N and deuterated labeled Hydrochlorothiazide ( HY-B0252 ). Hydrochlorothiazide (HCTZ), an orally active diuretic agent of the thiazide class, inhibits transforming TGF-β/Smad signaling pathway. Hydrochlorothiazide has direct vascular relaxant effects via opening of the calcium-activated potassium (KCA) channel. Hydrochlorothiazide improves cardiac function, reduces fibrosis and has antihypertensive effect.

Application

Products | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Cancer | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Signaling Pathways > TGF-beta/Smad | Products > Signaling Pathways > Stem Cell/Wnt | Products > Signaling Pathways > Others | Products > Research Areas > Metabolic Disease | Products > Research Areas > Cardiovascular Disease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Stem Cells | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Potassium Channel | Products > Signaling Pathways > TGF-beta/Smad | Products > Signaling Pathways > Isotope-Labeled Compounds

Product Information

• Catalog No.: HY-B0252S3
• CAS No.: 2140316-81-8
• Molecular Formula: C613CH6D2ClN15N2O4S2
• Molecular Weight: 302.73
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.
• Availability: In-stock

Source

Original product source